1.Myeloproliferative neoplasms:ten years after the discovery of JAK2 V617F gene mutation
Journal of Leukemia & Lymphoma 2015;24(7):385-387
This article focuses on the rapidly evolving understanding of the molecular pathogenetic mechanisms of the bcr-abl-negative myeloproliferative neoplasms (MPN) [myeloproliferative disorders (MPD)],such as polycythemia vera (PV),essential thrombocythemia (ET),and primary myelofibrosis (MF).The amplify therapies were reviewed and IFN-α is an effective agent for these MPN (MPD).Also,the article emphasize once again avoidance MPN and select MPD for such chinese patients.
2.Review and prospects on research and application of hematopoietic stem cell transplantation
Journal of Leukemia & Lymphoma 2013;22(6):327-330
The outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been improved over past 50 years due to the advances in HLA matching and increasing sources of HSC donors,such as developments and progressions of HLA-matched sibling donor transplantation (MSDT),umbilical cord transplantation (UCBT/CBT),unrelative donor transplantation (URDT),and HLA haploidentical transplantation (haplo-SCT).To review and discuss progressions in field of allo-HSCT,we studied relative advances reports of Education Program Book,54th-ASH,2012.Howeover,the outcomes of allo-HSCT can be quite different according to different diseases,disease phase or patient age.Furthermore,according to our local experiences,we emphasize again significance of HSCT donor safety.
3.Current treatment of acute myeloid leukemia by targeting leukemia stem cells
Journal of Leukemia & Lymphoma 2013;22(7):395-398
Acute myeloid leukemia (AML) originates from rare leukemia stem cells (LSC).Because these chemotherapy-resistant LSC are thought to underlie disease relapse,effective therapeutic strategies specifically targeting these cells may be beneficial.With the increasing knowledge regarding the LSC,several major directions in targeted therapies with regard to LSC are being investigated.These include targeting cell surface molecules,signal pathways,and microenvironment of LSC.Since eliminating LSC-should provide an efficient,potentially curative treatment option for leukemia patients,this article reviews the recent progress of LSC targeting in AML therapy.
4.Risks and control of complete market-oriented reforms of medical institutions
Journal of Central South University(Medical Sciences) 2014;(4):423-427
Marketization has become the mainstream since the new public management emerges globally in second half of the 20th century. Some countries infuse private capital into medical institutions which used to be managed by the government originally, and cause the medical industry reforms to be market-oriented. Market-oriented reforms of medical institutions may have risks in the following aspects: the risk of uneven distribution of medical resources, the risk of market failure, the moral risk of government renting-seeking and corruption and the decay of social justice values. Measures of controlling these risks include deifning the function orientation of the government, completing the institution-building of healthcare system, improving primary medical system and strengthening social consciousness of hospitals.
5.Research status of hippocampal dysfunctions caused by cranial irradiation
Chinese Journal of Radiological Medicine and Protection 2016;36(9):712-716
Cranial irradiation is routinely used for the treatment of almost all brain tumors,but it may cause disastrous injury in brain,especially in the hippocampus that has cognitional and emotional regulation functions.Several studies have investigated the mechanisms of radiation-induced hippocampal dysfunctions such as hippocampal neurogenesis,neurotrophin and neuroinflammation,and provided effective prevention strategies such as exercise,environmental enrichment,anti-inflammatory and intrahippocampal transplantation of neural stem cells.This review discussed the curent progresses and challenges of hippocampal dysfunction induced by cranial irradiation and provided new insights for preclinical and clinical researches.
6.Biological characteristics and clinical implications of CALR mutations in classic myeloproliferative neoplasms
Journal of Leukemia & Lymphoma 2015;24(7):420-423,427
CALR mutations are discovered in classic myeloproliferative neoplasms (MPN) as a new biomarker very recently.CALR mutations occur in about 20 %-35 % essential thrombocythemia and primary myelofibrosis and are associated with some clinical features and favorable prognostic impact.This article reviews biological characteristics and clinical implications of CALR mutations in classic MPN.
7.Research on the development of database for the monitoring of radiation dose in cardiovascular interventional procedures
Jimian ZHANG ; Yuan TIAN ; Yanqiu DING
China Medical Equipment 2014;(1):28-29
Objective:A database was designed and developed for effective utilization monitoring data of radiation dose to patients and occupational operators in cardiovascular interventional procedures. Methods:To complete a command reception of the client program, data display and other functions, compiled database software using MS Visual Basic level programming language. Using MS Access database completed data storage, management and maintenance. Results:The database was designed according to technological indicator acknowledged;the relevant help file was set up. The database includes two sub-libraries professional database and patient database. Professionals and patients can be recorded separately input, record view and record query. Conclusion:The data platform for monitoring data of radiation dose in cardiovascular interventional procedures was provided, which can provide basic data for constituting normalization and technical standard of dose limited of radiation dose to patients and occupational operators in cardiovascular interventional procedures.
8.Clinical experience of treating accelerated rejection of cadaver renal transplantation
Xiaoming DING ; Wujun XUE ; Puxun TIAN
Journal of Xi'an Jiaotong University(Medical Sciences) 2000;21(5):483-485
Objective To discuss the way of treating accelerated rejection. Methods Seven patients of accelerated rejection were treated by efficient anti-rejection treatment. ResultsSix patients of accelerated rejection were reversed by efficient treatment of anti-rejection. One allograft was removed because treatment was invalid. And six patients were still alive, the longest survival one has reached to 3 years. ConclusionThe treatment emphasis of accelerated rejection should be focused on 3 aspects, including early diagnosis, efficient treatment in time, and paying more attention to any possible complications during the process of treatment.
9.Protective effects of green tea polyphenol(-) epigallocatechin gallate on cultured cortical neurons in mice
Yinxiu DING ; Jianying TIAN ; Jiangbo MA
Chinese Pharmacological Bulletin 1987;0(01):-
Aim To observe the protective effects of epigallocatechin gallate(EGCG)on cortical neurons of embryonic mice the injury by FeSO4/H2O2 in vitro.Methods The cell injury model was established with FeSO4/H2O2 for 24 h.The process of the growth and morphology of the neurons were observed under phase contrast microscope in vitro.The cell survival was analyzed using colormetric neutral red assay.The cortical neuronal viability was analyzed using MTT assay.TBARS method was performed to detect the levels of Malondialdehyde(MDA).The composing capacity of total protein was measured by BCA method.Results As compared with FeSO4/H2O2,EGCG enhanced the mouse cortical neuronal survivality and viability,decreased the levels of MDA and increased the composing capacity of total protein.Conclusion EGCG exerted protective effects on cortical neurons the injury induced by FeSO4/H2O2,which may be related to free radial scavenging activity and lipid peroxidation process being inhabited.
10.The effects of diltiaze in renal transplantation patients treated with cyclosporine A
Wujun XUE ; Xiaoming DING ; Puxun TIAN
Chinese Journal of Organ Transplantation 2003;0(01):-
Objective To investigate the clinical effects of diltiaze in renal transplantation patients treated with cyclosporine A (CsA). Methods 1529 renal transplant cases were randomly ~divi -ded into experimental group 1 receiving CsA, Aza, Pred and Diltiaze, experimental group 2 receiving CsA, MMF, Pred and diltiaze, and control group receiving CsA, Aza and Pred without diltiaze. The dosage and blood concentrations of CsA, the outcome of renal transplant, the incidence of acute rejection, and the hepatic and renal toxicity were observed in the experimental groups and control group.Results The dosage of CsA in experimental group 1 was less, while the blood concentrations of CsA was higher than in control group (P~0.05 ). The recovery time of the graft function was cut down to 4.7 days (experimental group 1) and 3.9 days (experimental group 2) respectively with the difference being significant between the experimental groups and control group (P